Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,accountsPayable,longTermInvestments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,shortName,esgPopulated,tradeable,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchangeDataDelayedBy,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,longName,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingPE,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,DTMXF,11990984.0,292768992,,,10482954,,9560351,1321509,10929040,6156905,6156905,-8142,-10936,,,,922603,19045888,12888983,8116848,4326049,,9560351,9560351,2150545.0,6957401.0,7162882.0,17863877.0,2184665.0,25026759.0,34036909.0,-23120905.0,618507.0,3722348.0,-9528.0,4619908.0,6467940.0,317168.0,-9528.0,129545.0,19024321.0,4973924.0,9376410.0,60000.0,3935736.0,,548590,-8477,-91985,939015,180259,1031000,2647921,5525,1711858,190366,-7709169,-1058539,-8477,12556381.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,DATAMETREX AI LIMITED,False,False,PNK,0.1431,1630436905,0.0,0.14662,0.1431,0.1431,1,REGULAR,0,4,0.0,0.1431 - 0.1431,0.1431,0.0,0.0,0,0,finmb_415303388,Datametrex AI Limited,Other OTC,CAD,53515,43724,0.13209999,12.009089,0.011 - 0.3129,-0.16980001,-0.5426654,0.011,0.3129,11.007691,0.013,0.061,0.15058473,-0.007484734,-0.04970447,0.18267043,-0.039570436,-0.21662201,41895240,2.3459015,15,America/New_York,EDT,-14400000,4.23,,,0.3129,0.011,0.1506,0.1827,53.52k,43.72k,292.77M,,287.3M,3.07%,0.00%,,,,,,,,,,,0.00%,,,2:1,"May 25, 2017","Dec 30, 2020","Mar 30, 2021",17.23%,8.62%,10.05%,51.88%,30.61M,0.12,"2,253.10%",2.99M,3.36M,5.28M,0.0130,,9.59M,0.03,423.97k,2.37,2.94,0.06,1.26M,1.21M,Value,M2N 6K8,Technology,"Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.",Toronto,647 400 8494,ON,1577750400,Canada,http://www.datametrex.com,86400,4711 Yonge Street,Information Technology Services,10th Floor Suite 1000
t-1,DTMXF,-2047288.0,292768992,,,-2346177,,-2964684,1098264,643786,-2277253,-2277253,355523,-7801,,,,618507,4751903,7029156,4108117,-68924,,-2964684,-2964684,2321297.0,5249497.0,6751972.0,3246357.0,2188320.0,9998329.0,30695409.0,-32681256.0,618507.0,2972348.0,-17293.0,1971987.0,6053667.0,407489.0,-17293.0,141192.0,3873566.0,,1667241.0,60000.0,3426567.0,689926.0,998119,37157,-54032,71968,-14604,126000,558613,-42915,492403,172779,323364,1977429,-4050,-2180101.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,DATAMETREX AI LIMITED,False,False,PNK,0.1431,1630436905,0.0,0.14662,0.1431,0.1431,1,REGULAR,0,4,0.0,0.1431 - 0.1431,0.1431,0.0,0.0,0,0,finmb_415303388,Datametrex AI Limited,Other OTC,CAD,53515,43724,0.13209999,12.009089,0.011 - 0.3129,-0.16980001,-0.5426654,0.011,0.3129,11.007691,0.013,0.061,0.15058473,-0.007484734,-0.04970447,0.18267043,-0.039570436,-0.21662201,41895240,2.3459015,15,America/New_York,EDT,-14400000,4.23,,,0.3129,0.011,0.1506,0.1827,53.52k,43.72k,292.77M,,287.3M,3.07%,0.00%,,,,,,,,,,,0.00%,,,2:1,"May 25, 2017","Dec 30, 2020","Mar 30, 2021",17.23%,8.62%,10.05%,51.88%,30.61M,0.12,"2,253.10%",2.99M,3.36M,5.28M,0.0130,,9.59M,0.03,423.97k,2.37,2.94,0.06,1.26M,1.21M,Value,M2N 6K8,Technology,"Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.",Toronto,647 400 8494,ON,1577750400,Canada,http://www.datametrex.com,86400,4711 Yonge Street,Information Technology Services,10th Floor Suite 1000
t-2,DTMXF,-665169.0,292768992,,,-451353,,-451353,680893,1160482,-428244,-428244,105319,-10898,,,,0,4862325,5290569,3701843,-23109,,-451353,-451353,2492049.0,4018967.0,5160708.0,4799228.0,2413782.0,9959936.0,30509292.0,-29716572.0,,2972348.0,-12459.0,1413374.0,5080708.0,448940.0,-12459.0,63996.0,3913749.0,,2280641.0,80000.0,2215986.0,517794.0,680206,-30566,-19180,464340,155541,483520,835376,13365,388237,190971,-791949,604821,-4050,-1166959.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,DATAMETREX AI LIMITED,False,False,PNK,0.1431,1630436905,0.0,0.14662,0.1431,0.1431,1,REGULAR,0,4,0.0,0.1431 - 0.1431,0.1431,0.0,0.0,0,0,finmb_415303388,Datametrex AI Limited,Other OTC,CAD,53515,43724,0.13209999,12.009089,0.011 - 0.3129,-0.16980001,-0.5426654,0.011,0.3129,11.007691,0.013,0.061,0.15058473,-0.007484734,-0.04970447,0.18267043,-0.039570436,-0.21662201,41895240,2.3459015,15,America/New_York,EDT,-14400000,4.23,,,0.3129,0.011,0.1506,0.1827,53.52k,43.72k,292.77M,,287.3M,3.07%,0.00%,,,,,,,,,,,0.00%,,,2:1,"May 25, 2017","Dec 30, 2020","Mar 30, 2021",17.23%,8.62%,10.05%,51.88%,30.61M,0.12,"2,253.10%",2.99M,3.36M,5.28M,0.0130,,9.59M,0.03,423.97k,2.37,2.94,0.06,1.26M,1.21M,Value,M2N 6K8,Technology,"Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.",Toronto,647 400 8494,ON,1577750400,Canada,http://www.datametrex.com,86400,4711 Yonge Street,Information Technology Services,10th Floor Suite 1000
t-3,DTMXF,-1635120.0,292768992,,,-868478,,-868478,488401,781840,-813526,-813526,348637,-14024,,,,0,1954394,2767920,1172554,-54952,,-868478,-868478,2662801.0,3441190.0,4677405.0,4000029.0,2411914.0,8677434.0,29817781.0,-29265219.0,,2972348.0,6277.0,577998.0,4597405.0,468490.0,6277.0,105420.0,2410778.0,,1457916.0,80000.0,1708142.0,526087.0,-704729,-15990,78550,1897234,-335605,1818684,551050,1223,-1331417,185076,-212206,602117,-12352,-2186627.0,en-US,US,EQUITY,False,Delayed Quote,USD,us_market,DATAMETREX AI LIMITED,False,False,PNK,0.1431,1630436905,0.0,0.14662,0.1431,0.1431,1,REGULAR,0,4,0.0,0.1431 - 0.1431,0.1431,0.0,0.0,0,0,finmb_415303388,Datametrex AI Limited,Other OTC,CAD,53515,43724,0.13209999,12.009089,0.011 - 0.3129,-0.16980001,-0.5426654,0.011,0.3129,11.007691,0.013,0.061,0.15058473,-0.007484734,-0.04970447,0.18267043,-0.039570436,-0.21662201,41895240,2.3459015,15,America/New_York,EDT,-14400000,4.23,,,0.3129,0.011,0.1506,0.1827,53.52k,43.72k,292.77M,,287.3M,3.07%,0.00%,,,,,,,,,,,0.00%,,,2:1,"May 25, 2017","Dec 30, 2020","Mar 30, 2021",17.23%,8.62%,10.05%,51.88%,30.61M,0.12,"2,253.10%",2.99M,3.36M,5.28M,0.0130,,9.59M,0.03,423.97k,2.37,2.94,0.06,1.26M,1.21M,Value,M2N 6K8,Technology,"Datametrex AI Limited, together with its subsidiaries, sells COVID-19 test kits. The company offers nucleic acid, antigen, and antibody detection kits. It also provides big data, artificial intelligence, and system integration services. In addition, the company offers NexaIntelligence and NexaAGENT deep analytics platform, as well as is involved in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. Further, it operates a telehealth and urgent medical care platform. The company operates in Canada and Korea. Datametrex AI Limited is headquartered in Toronto, Canada.",Toronto,647 400 8494,ON,1577750400,Canada,http://www.datametrex.com,86400,4711 Yonge Street,Information Technology Services,10th Floor Suite 1000
